1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
CMB Biomedical Research Fellowship in China is sponsored by China Medical Board Inc.. This program supports U.S. scholars in the biomedical sciences, including medical students, graduate students, and early-career researchers, to undertake mentored research projects at select academic and research institutions in China. The fellowship aims to develop the next generation of American medical research leaders focused on China through a training experience similar to NIH Fogarty International Center fellowships.
Geographic focus: China
Focus areas: Biomedical Research, Public Health, Health Professions Education, Global Health
Get alerted about grants like this
Save a search for “China Medical Board Inc.” or related topics and get emailed when new opportunities appear.
Search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Health Policy and Systems Sciences Health Professional Education CMB Foundation Welcomes Dr. Thaksaphon (Mek) Thamarangsi as Chief Representative and Director of the CMB Bangkok Office CMB Foundation is pleased to announce the appointment of Dr. Thaksaphon Thamarangsi as Chief Representative and Director of the Bangkok Office, effective January 1, 2026. Commonly known by his nickname ‘Mek’, Dr....
Public Health Thank You Day Support for public health has been a significant part of CMB’s work since its earliest days, when John Grant and C. C. Chen of Peking Union Medical College started the first public health...
Training Course in Vietnam: Emergent Management of Traumatic Brain Injury In the United States, the EPIC (Excellence in Prehospital Injury Care) Project has successfully promulgated evidence-focused guidelines for in-hospital and pre-hospital traumatic brain injury (TBI) treatment. With grant support from CMB, a...
Global Learning I: A Deep Dive into New Zealand’s Approach to Health and Racial Equity The 2024 Equity Initiative Fellows traveled to New Zealand for Global Learning I to explore health equity as well as historical, cultural and diversity perspectives outside of Asia. Held May 3-11, this was the...
CMB Announces New Fellowship Program for U.S. Postdoctoral Researchers CMB has initiated support for a postdoctoral research fellowship program that will give U.S. scholars from the health professions and biomedical sciences an opportunity to spend 1-2 years at selected academic and... 2024 EI Fellows Connect at the Opening Retreat “We heard real stories [from Fellows] of courage to get through their difficulties in life.
It was like watching a Netflix original series of very different, amazing stories around Southeast Asia that are very... Shuyang Zhang: A Leader in China’s Efforts to Tackle Rare Diseases Rare diseases, despite their name, encompass a vast array of conditions, affecting a significant number of people worldwide. Over 10,000 distinct rare diseases have been identified, affecting around 10 percent of people...
Sharing Lessons from COVID-19: A Video Collection When our Equity Initiative Fellows complete their induction year, they are welcomed into the global community of Atlantic Fellows. The Equity Initiative is one of 7 programs supported through the Atlantic Institute. Our Fellows...
Search Submit Clear Site by 501creative Health Policy and Systems Sciences Health Professional Education
According to the current listing, eligibility includes: U.S. citizens or permanent residents who have completed at least masters-level training in medicine, public health, nursing, or relevant biomedical field. Confirm the full requirements in the official notice before applying.
CMB Biomedical Research Fellowship in China is funded by China Medical Board Inc.. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
DARPA BTO pre-released four FY26 SBIR/STTR topics on April 30, 2026, with proposals due June 3. Two topics — SWiFT and EXPOSITION — offer Direct-to-Phase-II awards up to $1.5M, bypassing the standard Phase I gate. Here is what each topic is actually solving, why the DP2 structure matters, and how small biotech, surgical robotics, and battlefield-medicine teams should decide whether to compete.
Read articleOn June 3, 2026, four DARPA Biological Technologies Office SBIR topics close simultaneously — SWiFT, BARK, EXPOSITION, and Medical Swarm Robotics. Combined Phase I plus Phase II potential exceeds $6 million per company, and together they sketch a coherent strategy of distributed, autonomous, dual-species combat casualty care that depends on small businesses, not primes, to actually build.
Read articleThe BARK program funds dual-use medical products for warfighters and military working dogs — tourniquets, sensors, drug delivery, and CBRN countermeasures. Proposals close June 3, 2026.
Read article